Additionally, among the top 20 mutated oncogenic genes in the low-DR group, we identified mutations that closely correlated with tumour progression, such as those in APC and FAT3,71,72 indicating a more malignant characteristic of the tumours in low-DR patients. The gene discussed is APC; the disease is neoplasm.